A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452
一项随机 I/II 期安全性和免疫原性研究,评估了蒙塔尼德佐剂 SARS-CoV-2 刺突蛋白-RBD-Fc 疫苗 AKS-452 的安全性和免疫原性。
期刊:
影响因子:
doi:10.1016/j.vaccine.2023.02.057
Feitsma, Eline A; Janssen, Yester F; Boersma, Hendrikus H; van Sleen, Yannick; van Baarle, Debbie; Alleva, David G; Lancaster, Thomas M; Sathiyaseelan, Thillainaygam; Murikipudi, Sylaja; Delpero, Andrea R; Scully, Melanie M; Ragupathy, Ramya; Kotha, Sravya; Haworth, Jeffrey R; Shah, Nishit J; Rao, Vidhya; Nagre, Shashikant; Ronca, Shannon E; Green, Freedom M; Aminetzah, Ari; Sollie, Frans; Kruijff, Schelto; Brom, Maarten; van Dam, Gooitzen M; Zion, Todd C